EBIT: Income before interest and taxes.
Hoth Therapeutics, Inc. (HOTH) had EBIT of $-7.69M for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
-- |
|
$-7.85M |
|
-- |
|
-- |
|
$7.69M |
|
$-7.69M |
|
$-0.15M |
|
$-7.85M |
|
$-7.64M |
|
$-7.85M |
|
$-7.85M |
|
$-7.85M |
|
$-7.64M |
|
EBIT |
$-7.69M |
$-7.69M |
|
3.41M |
|
3.41M |
|
$-2.30 |
|
$-2.30 |
|
Balance Sheet Financials | |
$9.43M |
|
-- |
|
$0.09M |
|
$9.52M |
|
$0.68M |
|
-- |
|
$0.03M |
|
$0.70M |
|
$8.82M |
|
$8.82M |
|
$8.82M |
|
4.35M |
|
Cash Flow Statement Financials | |
$-8.45M |
|
-- |
|
$11.32M |
|
$6.43M |
|
$9.29M |
|
$2.87M |
|
$0.22M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
13.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.45M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-89.00% |
|
-89.00% |
|
-82.41% |
|
-89.00% |
|
$2.03 |
|
$-2.48 |
|
$-2.48 |